Achalasia, a chronic motility disorder of the esophagus characterized by aperistalsis and loss of relaxation function of the lower esophageal sphincter, causes substantial morbidity. [1][2][3] Epidemiologic estimates report an incidence of 2 to 11 per 100,000 and a prevalence of 11 to 162 per 100,000 in the United States, with considerable increases in burden associated with advancing age. [4][5][6] Symptoms of achalasia are generally severe and include dysphagia, regurgitation, heartburn, and weight loss, and the condition has been associated with a substantial decrement to health-related quality of life. [7][8][9] In addition to a high symptom burden, current